Invesco Ltd. Harvard Bioscience Inc Transaction History

Invesco Ltd.

$499 Billion
Q3 2024

A detailed history of Invesco Ltd. transactions in Harvard Bioscience Inc stock. As of the latest transaction made, Invesco Ltd. holds 16,123 shares of HBIO stock, worth $34,986. This represents 0.0% of its overall portfolio holdings.

Number of Shares

16,123

Previous 99,047 83.72%

Holding current value

$34,986

Previous $282,000 84.75%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$2.64 - $3.54 $218,919 - $293,550	-82,924 Reduced 83.72%	16,123 $43,000
Q2 2024 Aug 13, 2024	BUY	$2.77 - $4.63 $115,558 - $193,154	41,718 Added 72.77%	99,047 $282,000
Q1 2024 May 14, 2024	BUY	$4.02 - $5.39 $45,554 - $61,079	11,332 Added 24.64%	57,329 $243,000
Q4 2023 Feb 12, 2024	BUY	$4.0 - $5.49 $32,636 - $44,792	8,159 Added 21.56%	45,997 $246,000
Q3 2023 Nov 13, 2023	BUY	$4.0 - $5.82 $71,456 - $103,968	17,864 Added 89.44%	37,838 $162,000
Q2 2023 Aug 11, 2023	BUY	$4.19 - $6.16 $83,691 - $123,039	19,974 New	19,974 $109,000
Q2 2022 Aug 15, 2022	SELL	$3.28 - $6.42 $47,251 - $92,486	-14,406 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$5.16 - $7.14 $202,235 - $279,838	-39,193 Reduced 73.12%	14,406 $89,000
Q4 2021 Feb 14, 2022	SELL	$6.37 - $8.18 $89,670 - $115,149	-14,077 Reduced 20.8%	53,599 $378,000
Q3 2021 Nov 15, 2021	BUY	$6.98 - $8.47 $54,457 - $66,082	7,802 Added 13.03%	67,676 $473,000
Q2 2021 Aug 17, 2021	SELL	$5.44 - $8.4 $56,744 - $87,620	-10,431 Reduced 14.84%	59,874 $499,000
Q1 2021 May 17, 2021	SELL	$3.91 - $6.99 $38,943 - $69,620	-9,960 Reduced 12.41%	70,305 $383,000
Q4 2020 Feb 16, 2021	BUY	$3.0 - $4.5 $47,172 - $70,758	15,724 Added 24.36%	80,265 $344,000
Q3 2020 Nov 16, 2020	SELL	$2.75 - $4.2 $4,196 - $6,409	-1,526 Reduced 2.31%	64,541 $194,000
Q2 2020 Aug 14, 2020	BUY	$2.12 - $3.14 $19,224 - $28,473	9,068 Added 15.91%	66,067 $205,000
Q1 2020 May 15, 2020	BUY	$1.42 - $3.29 $80,938 - $187,526	56,999 New	56,999 $126,000

Others Institutions Holding HBIO

# of Institutions

Shares Held

31.5M

Call Options Held

700

Put Options Held

2.1K

View Full List

About HARVARD BIOSCIENCE INC

Ticker HBIO
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 41,636,500
Market Cap $90.4M
Description
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...

More about HBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account